Introduction

Steam sterilisation remains the most widely used and reliable method for achieving sterility in pharmaceutical manufacturing. Whether applied to terminal sterilisation of finished product, sterilisation of components or porous loads, or sterilisation of equipment & fixed Pipework (SIP Systems), steam processes must be robust, reproducible, and demonstrably effective.

A critical element of steam sterilisation qualification is the use of biological indicators (BIs). While physical measurements such as temperature, pressure, and time confirm that cycle parameters are met, only biological indicators provide direct evidence of microbial lethality. This blog explores the role of biological indicators in steam sterilisation qualification studies, their selection, placement, use, and interpretation within a regulated pharmaceutical environment.

What Are Biological Indicators?

Biological indicators are standardised test systems containing defined populations of highly resistant spore forming microorganisms. For steam sterilisation, Bis for Overkill processes typically consist of spores of Geobacillus stearothermophilus, a thermophilic organism chosen because of its high resistance to moist heat. Other biological indicator organisms may be used for qualification of Terminal Sterilisation processes using the BI/Bioburden approach.

Each BI is characterised by:

• A known population of spores (e.g. 10⁶)
• A defined D‑value (time required at a specific temperature to reduce the population by 90%)
• A defined z‑value (temperature change required to change the D‑value by a factor of 10)

These characteristics allow biological indicators to act as challenge devices, intentionally providing microbiological challenge to test sterilisation efficacy.

Why Biological Indicators Are Required

Sterilisation qualification relies on a combination of:

• Physical qualification (temperature, pressure, time)

• Biological indicators

While physical data can show that a steriliser met its programmed conditions, it does not prove that microorganisms were destroyed at the hardest‑to‑sterilise locations. Biological indicators serve this purpose by:

• Confirming actual microbial inactivation
• Challenging the sterilisation process with a highly resistant organism
• Supporting calculation and verification of sterility assurance levels (SAL)
• Demonstrating process capability during worst‑case conditions

From a regulatory standpoint, biological indicators provide evidence that a sterilisation process is fit for purpose.

Role of Biological Indicators in Steam Sterilisation Qualification

Biological indicators are primarily used during qualification and requalification activities, including:

Installation Qualification (IQ)

BIs are not typically used during IQ, which focuses on correct installation and instrumentation.

Operational Qualification (OQ)

During OQ, BIs may be used to:

• Confirm steriliser functionality across operating ranges
• Support the identification of cold spots or poor steam penetration
• Correlate physical data with biological lethality
• Used to demonstrate an appropriate log reduction was achieved in the most challenging locations within the load item before moving to PQ.

Performance Qualification (PQ)

Biological indicators are essential during PQ and are used to:

• Demonstrate consistent achievement of sterility under worst‑case loads
• Confirm penetration of saturated steam into product, component, or equipment loads
• Correlate with temperature data and other physical parameters

PQ typically involves multiple successful sterilisation runs with all BIs showing complete inactivation.

Selection of Biological Indicators

For steam sterilisation qualification, the BI must be appropriate for the process. Key selection criteria include:

• Organism: Geobacillus stearothermophilus
• Indicator type:
  • Spore strips
  • Self‑contained BIs (spores + growth medium)
  • Spore Suspension for direct inoculation of surfaces or product
• Population and D‑value aligned with the cycle design
• Supplier certification demonstrating compliance with recognised standards
• Compatibility with incubation and laboratory methods used on site

Self‑contained BIs are often preferred in pharmaceutical environments due to ease of use, reduced handling risk, and faster results.

Biological Indicator Placement Strategy

Correct placement of BIs is critical to obtaining meaningful results. Biological indicators should be positioned in locations representing worst‑case conditions, such as:

• Cold spots identified during temperature mapping
• Areas with restricted steam access
• Inside product containers, tubing, or porous materials
• Within representative load items

The BI placement strategy should be:

• Defined in the qualification protocol
• Justified by heat distribution and penetration data
• Consistent across qualification runs

Poor BI placement or lack of defined strategy is a common inspection finding and can undermine an otherwise well‑designed validation study.

Incubation and Interpretation of Results

After exposure, biological indicators are incubated under defined conditions, typically:

• 55–60 °C for G. stearothermophilus
• For a defined duration (e.g. 24–48 hours or per supplier instructions)

Result Interpretation

• No growth: Indicates successful sterilisation at the BI location
• Growth detected: Indicates process failure or inadequate lethality if complete kill of the organism is the target of the study
• Growth Detected: Enumeration of surviving populationand determining appropriate log reduction of challenge biological indicator organisms

Positive growth in studies designed for a complete kill of the biological Indicator requires:

• Immediate investigation
• Assessment of physical data
• Review of BI handling, placement, and incubation
• Potential repeat qualification or cycle adjustment

Appropriate positive and negative controls must always be included to confirm BI viability and test validity.

Limitations of Biological Indicators

While essential, BIs are not without limitations:

• They provide discrete data points, not continuous monitoring
• Results are retrospective (after incubation)
• Improper handling can lead to false positives or negatives
• They should not replace robust cycle design or physical monitoring

For this reason, biological indicators must be used as part of a holistic qualification strategy, supported by sound sterilisation science and physical data.

Regulatory Expectations and Best Practice

Regulatory authorities expect:

• Scientifically justified BI selection
• Clearly defined placement rationale
• Successful BI results during PQ
• Documented investigation procedures for failures
• Periodic requalification using BIs, appropriate to risk

Best practice includes:

• Linking BI outcomes to F₀ calculations
• Using BIs strategically through appropriate risk assessment
• Ensuring strong alignment between validation, microbiology, and engineering teams

Conclusion

Biological indicators play a pivotal role in steam sterilisation qualification studies by providing direct, microbiological evidence of process lethality. When correctly selected, placed, and interpreted, they strengthen the scientific and regulatory justification for sterilisation processes used in pharmaceutical manufacturing.

For training and GMP compliance purposes, understanding not just how to use biological indicators—but why they are used and how inspectors evaluate their application—is essential. A well‑designed sterilisation qualification supported by appropriate use of BIs is the foundation of sterility assurance and patient safety.